PT - JOURNAL ARTICLE AU - Kareem A. Wahid AU - Sara Ahmed AU - Renjie He AU - Lisanne V. van Dijk AU - Jonas Teuwen AU - Brigid A. McDonald AU - Vivian Salama AU - Abdallah S.R. Mohamed AU - Travis Salzillo AU - Cem Dede AU - Nicolette Taku AU - Stephen Y. Lai AU - Clifton D. Fuller AU - Mohamed A. Naser TI - Development of a High-Performance Multiparametric MRI Oropharyngeal Primary Tumor Auto-Segmentation Deep Learning Model and Investigation of Input Channel Effects: Results from a Prospective Imaging Registry AID - 10.1101/2021.07.27.21261114 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.27.21261114 4099 - http://medrxiv.org/content/early/2021/07/30/2021.07.27.21261114.short 4100 - http://medrxiv.org/content/early/2021/07/30/2021.07.27.21261114.full AB - Background and Purpose Oropharyngeal cancer (OPC) primary gross tumor volume (GTVp) segmentation is crucial for radiotherapy. Multiparametric MRI (mpMRI) is increasingly used for OPC adaptive radiotherapy but relies on manual segmentation. Therefore, we constructed mpMRI deep learning (DL) OPC GTVp auto-segmentation models and determined the impact of input channels on segmentation performance.Materials and Methods GTVp ground truth segmentations were manually generated for 30 OPC patients from a clinical trial. We evaluated five mpMRI input channels (T2, T1, ADC, Ktrans, Ve). 3D Residual U-net models were developed and assessed using leave-one-out cross-validation. A baseline T2 model was compared to mpMRI models (T2+T1, T2+ADC, T2+Ktrans, T2+Ve, all 5 channels [ALL]) primarily using the Dice similarity coefficient (DSC). Sensitivity, positive predictive value, Hausdorff distance (HD), false-negative DSC (FND), false-positive DSC, surface DSC, 95% HD, and mean surface distance were also assessed. For the best model, ground truth and DL-generated segmentations were compared through a Turing test using physician observers.Results Models yielded mean DSCs from 0.71 (ALL) to 0.73 (T2+T1). Compared to the T2 model, performance was significantly improved for HD, FND, sensitivity, surface DSC, and 95% HD for the T2+T1 model (p<0.05) and for FND for the T2+Ve and ALL models (p<0.05). There were no differences between ground truth and DL-generated segmentations for all observers (p>0.05).Conclusion DL using mpMRI provides high-quality segmentations of OPC GTVp. Incorporating additional mpMRI channels may increase the performance of certain evaluation metrics. This pilot study is a promising step towards fully automated MR-guided OPC radiotherapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health (NIH) through a Cancer Center Support Grant (P30-CA016672-44). K.A. Wahid and T. Salzillo are supported by training fellowships from The University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences TL1 Program (TL1TR003169). S. Ahmed and M.A. Naser are supported by an NIH National Institute of Dental and Craniofacial Research (NIDCR) Award (R01 DE028290-01). R. He, A.S.R. Mohamed, and S.Y. Lai are supported by a NIH NIDCR Award (R01 DE025248). L.V. van Dijk receives funding and salary support from the Dutch organization NWO ZonMw during the period of study execution via the Rubicon Individual career development grant. B.A. McDonald receives research support from an NIH NIDCR Award (F31DE029093) and the Dr. John J. Kopchick Fellowship through The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences. C.D. Fuller received funding from an NIH NIDCR Award (1R01 DE025248-01/R56 DE025248) and Academic-Industrial Partnership Award (R01 DE028290); the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01 CA214825); the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01 CA218148); the NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30 CA016672); the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007); and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25 EB025787). He has received direct industry grant support, speaking honoraria, and travel funding from Elekta AB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Images were collected from August 2018-August 2019 under a HIPAA-compliant protocol approved by The University of Texas MD Anderson Cancer Centers IRB (RCR03-0800). The protocol included a waiver of informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized datasets are planned to be uploaded to a public repository in the near future. Until this time, anonymized data are available from the authors upon reasonable request.